Pharmaceutical industry news

NIH award: Shared Resource Management

Recipient: THOMAS JEFFERSON UNIVERSITY. Award amount: 948323.

NIH award: Community Outreach and Engagement

Recipient: THOMAS JEFFERSON UNIVERSITY. Award amount: 356557.

NIH award: Research Program: Molecular Oncology Regulation Approaches (MORA)

Recipient: THOMAS JEFFERSON UNIVERSITY. Award amount: 64162.

NIH award: Research Program: Cancer Risk and Control (CRiC)

Recipient: THOMAS JEFFERSON UNIVERSITY. Award amount: 64162.

NIH award: Translational Research in Cancer

Recipient: THOMAS JEFFERSON UNIVERSITY. Award amount: 3065902.

NIH award: Michigan Center for Urban African American Aging Research - COMMUNITY LIAISON AND RECRUITMENT CORE (CLRC)

Recipient: UNIVERSITY OF MICHIGAN AT ANN ARBOR. Award amount: 150948.

NIH award: Michigan Center for Urban African American Aging Research - Leadership and Administrative Core (LAC)

Recipient: UNIVERSITY OF MICHIGAN AT ANN ARBOR. Award amount: 339542.

NIH award: Virtual Reality-Based Cognitive Stimulation Games for Enhancing Attention and Preventing Delirium in Older Surgical Patients with Cognitive Impairment: A Randomized Controlled Pilot Trial

Recipient: METHODIST HOSPITAL RESEARCH INSTITUTE. Award amount: 242840.

NIH award: Clinical and Technology Research Resources Core (CTRR)

Recipient: UNIVERSITY OF PUERTO RICO MED SCIENCES. Award amount: 344041.

NIH award: English Longitudinal Study of Ageing - Renewal 2024

Recipient: UNIVERSITY COLLEGE LONDON. Award amount: 747209.

NIH award: Neural Inflammation and Exercise Pressor Reflex in Heart Failure

Recipient: UNIVERSITY OF NEBRASKA MEDICAL CENTER. Award amount: 615663.

NIH award: Dissecting Cell Type Specific Functions of CHD7 in Development of the Neocortex

Recipient: UNIVERSITY OF MICHIGAN AT ANN ARBOR. Award amount: 516297.

NIH award: Prevention and Early-Stage Treatment of Chronic Diseases

Recipient: UNIVERSITY OF MICHIGAN AT ANN ARBOR. Award amount: 260960.

NIH award: Training Grant in Cell and Molecular Dermatology

Recipient: UNIVERSITY OF MICHIGAN AT ANN ARBOR. Award amount: 241073.

NIH award: 2-Generation Interventions to Improve Cardiovascular Health in Indiana and Illinois Through Home Visiting (2-NOURISH)

Recipient: NORTHWESTERN UNIVERSITY. Award amount: 951711.

NIH award: Continuous Positive Airway Pressure, Arousability and Links to Mechanisms in Obstructive Sleep Apnea (CALM-OSA).

Recipient: YALE UNIVERSITY. Award amount: 744547.

NIH award: RNA Aptamers as Probes and Modulators of Coagulation

Recipient: CHILDREN'S HOSP OF PHILADELPHIA. Award amount: 491682.

NIH award: Structural Correlates of (Pro)Cofactor Function

Recipient: CHILDREN'S HOSP OF PHILADELPHIA. Award amount: 491683.

NIH award: Advanced Technologies Core (Core D)

Recipient: VANDERBILT UNIVERSITY MEDICAL CENTER. Award amount: 276435.

NIH award: Developmental Core (Core B)

Recipient: VANDERBILT UNIVERSITY MEDICAL CENTER. Award amount: 245227.

NIH award: Clemson University Genomics and Bioinformatics Facility (CUGBF)

Recipient: CLEMSON UNIVERSITY. Award amount: 541282.

NIH award: Administrative Core - EPIC

Recipient: CLEMSON UNIVERSITY. Award amount: 320443.

NIH award: Training in Transfusion Medicine and Classical Hematology

Recipient: VERSITI BLOOD HEALTH, INC.. Award amount: 269218.

NIH award: Base editing to elucidate RAF regulation and signaling

Recipient: HARVARD UNIVERSITY. Award amount: 36323.

NIH award: Defining the role of G3BP1 in vascular development

Recipient: YALE UNIVERSITY. Award amount: 38098.

NIH award: Oral microbiome and inflammatory status in antimicrobially-treated oral cancer patients

Recipient: UNIVERSITY OF CALIFORNIA LOS ANGELES. Award amount: 626403.

NIH award: Geographic and Environmental Representation in Kidney Precision Medicine

Recipient: UNIV OF NORTH CAROLINA CHAPEL HILL. Award amount: 475632.

NIH award: Harnessing IL-10 in cART treated SIV infected macaques to restore immunity and to eradicate HIV

Recipient: EMORY UNIVERSITY. Award amount: 666681.

NIH award: Phase II study to evaluate the efficacy and safety of baricitinib for reduction of HIV in the central nervous system

Recipient: EMORY UNIVERSITY. Award amount: 619562.

NIH award: The Bidirectional Gut-Microbiota-Brain Axis in Parkinson’s disease: integrating mechanistic biomarkers of disease severity and progression

Recipient: RUSH UNIVERSITY MEDICAL CENTER. Award amount: 700162.

NIH award: Preventing and reducing alcohol use during pregnancy: Leveraging economic determinants and policies to inform health system interventions

Recipient: COLUMBIA UNIVERSITY HEALTH SCIENCES. Award amount: 177551.

NIH award: The Colorado Building Interdisciplinary Research Careers in Women's Health Program

Recipient: UNIVERSITY OF COLORADO DENVER. Award amount: 647601.

NIH award: CSF Oligomeric α-synuclein targeted nano scavengers as a Parkinson's disease theranostic

Recipient: BAYLOR COLLEGE OF MEDICINE. Award amount: 773511.

NIH award: Cognitive Neurocomputational Task Reliability and Clinical Applications Consortium

Recipient: WASHINGTON UNIVERSITY. Award amount: 3252372.

NIH award: Targeted Awareness and Education on Options in Uterine Fibroids

Recipient: MAYO CLINIC ROCHESTER. Award amount: 405693.

NIH award: Core A: Administrative Core

Recipient: UNIVERSITY OF PENNSYLVANIA. Award amount: 138124.

NIH award: Project 3: The role of sex in ART-associated changes in trophoblast behavior and epigenetics

Recipient: UNIVERSITY OF PENNSYLVANIA. Award amount: 276252.

NIH award: Core B: Education/Outreach Core

Recipient: UNIVERSITY OF PENNSYLVANIA. Award amount: 69063.

NIH award: Genipin’s ECM Crosslinking Action as an Agent to Prevent Neurodegeneration in Familial Dysautonomia

Recipient: UNIVERSITY OF GEORGIA. Award amount: 584626.

NIH award: Neuroscience Resident Research Program

Recipient: MASSACHUSETTS GENERAL HOSPITAL. Award amount: 418282.

NIH award: Substance Misuse and Family Violence Treatment for Fathers

Recipient: YALE UNIVERSITY. Award amount: 684118.

NIH award: Selective interactome vulnerability across the Alzheimer’s disease spectrum

Recipient: SLOAN-KETTERING INST CAN RESEARCH. Award amount: 2118427.

NIH award: Clinical progression and predictors of outcomes in congenital Zika syndrome

Recipient: RESEARCH TRIANGLE INSTITUTE. Award amount: 383492.

NIH award: Intersection of Periodontitis with HIV-Antiretroviral Therapy-Induced Immune Reconstitution Bone Loss, on Alveolar Bone and Tooth Loss, in People Living with HIV

Recipient: EMORY UNIVERSITY. Award amount: 354573.

NIH award: Provide a Set-It-And-Forget-it Copaxone Patch for Hourly Dosing of Medication to Combat Multiple Sclerosis.

Recipient: TRANSDERMAL SPECIALTIES GLOBAL, INC.. Award amount: 320863.

NIH award: Phospholipase C Isozymes

Recipient: UNIV OF NORTH CAROLINA CHAPEL HILL. Award amount: 427684.

NIH award: Establishing that sleep spindle and slow wave deficits are present, are associated with cognitive dysfunction, and can be acutely manipulated in early course schizophrenia

Recipient: UNIVERSITY OF PITTSBURGH AT PITTSBURGH. Award amount: 781301.

NIH award: Improving Maternal Cardiovascular Outcomes through the Implementation of a Hypertensive Disorders of Pregnancy Bundle in Nigeria

Recipient: WASHINGTON UNIVERSITY. Award amount: 152401.

NIH award: Thalamic Coordinated Reset Deep Brain Stimulation for Upper Extremity Essential Tremor: Proof of Principle Study

Recipient: UNIVERSITY OF MINNESOTA. Award amount: 850911.

NIH award: Dynamic Brain Imaging of Speech in Primary Progressive Aphasia

Recipient: UNIVERSITY OF CALIFORNIA, SAN FRANCISCO. Award amount: 797931.

Drug label update: Aspercreme Professional Cream

Official structured record identifier: ef297864-5917-4645-8ec7-f2bc49e037e8.

Drug label update: PENICILLIN G POTASSIUM

Official structured record identifier: 9e58122f-5c75-4905-a774-d3a4dae4ff8c.

Our Continued Commitment to the Hemophilia B Community: An Update on HEMGENIX® (etranacogene dezaparvovec-drlb) Supply and Patient Access

Advances in Pharmacological Therapy for Recurrent High-Grade Meningiomas.

Completion and outcomes of postmarketing requirements and commitments issued by the US Food and Drug Administration for new drugs, 2016-24: cross sectional evaluation of postmarketing studies.

The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) trial-rationale for the selected lower steroid dose.

Context Matters: Mapping Social Determinants of Health and Physical Function in Older People with HIV Using Geolocation Data.

Time-dependent effects of rapid-acting antidepressants in iPSC-derived neurons from treatment-resistant depression and healthy volunteers.

Gabapentinoids-duloxetine combination therapy for chronic pain: A mechanism oriented rational to bridge theoretical knowledge and real life setting.

Sustaining Drug Discovery Amid the Limits of Alzheimer's Disease Immunotherapies.